Myomo, Inc. Stock Added to Russell Microcap® Index

Rhea-AI Summary

Myomo, Inc. (NYSE American: MYO) announced its addition to the Russell Microcap® Index, effective today. This is a significant milestone aimed at raising the company's profile within the global investment community. Paul R. Gudonis, Myomo's representative, expressed enthusiasm about this inclusion, which enhances exposure to investment managers and institutions.

The membership in the Russell Microcap® Index lasts for one year, providing automatic inclusion in relevant growth and value indexes, which collectively benchmark approximately $10.6 trillion in assets.

Positive

• Inclusion in the Russell Microcap® Index enhances visibility and credibility among investors.
• Potential for increased investment interest and stock liquidity due to index inclusion.

Negative

• None.

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its stock will be added to the Russell Microcap^® Index at the opening of trading today.

"We are delighted that Myomo is now included in the Russell Microcap^® Index, a broadly used performance benchmark for smaller emerging growth stocks in the U.S.," stated Paul R. Gudonis. "This is an exciting milestone for Myomo to further raise awareness of our company within the global investment community and further our work to bring an improved quality of life to people suffering from upper limb paralysis.”

Membership in the Russell Microcap^® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell's U.S. indexes. Russell indexes are part of FTSE Russell, a leading global index provider.

For more information on the Russell Microcap^® Index and the Russell indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210628005182/en/

FAQ

When was Myomo added to the Russell Microcap Index?

Myomo was added to the Russell Microcap Index on the day of the announcement.

What is the significance of Myomo's inclusion in the Russell Microcap Index?

The inclusion provides Myomo with increased exposure to a broader investment community and may attract more institutional investors.

What are the benefits of being part of the Russell Microcap Index for MYO?

Being part of the index enhances the company's visibility and could lead to increased liquidity and investment interest.

How long will Myomo remain in the Russell Microcap Index?

Myomo's membership in the Russell Microcap Index is effective for one year.

What is the total asset benchmarked against Russell's U.S. indexes?

Approximately $10.6 trillion in assets are benchmarked against Russell's U.S. indexes.